Zimmer Biomet Holdings, Inc. (ZBH) income statement
ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3016% below fair value
$101.47−1.85 (-1.79%)
Close on Nov 19, 2026Market cap $19.35BP/E 24.7Yield 0.95%
Zimmer Biomet Holdings, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 69.9%
- Operating margin
- 14.2%
- Net margin
- 9.5%
- Return on equity, FY2025
- 5.6%
Financial strength
- Current ratio
- 1.69
- Debt to equity
- 0.59
- Debt to assets
- 32.8%
- Cash to current liabilities
- 13.6%
Valuation
- P/E ratio
- 24.7
- Price to sales
- 2.27
- Price to book
- 1.53
- Dividend yield
- 0.95%
See a number that looks wrong?